Incannex Healthcare logo

Incannex Healthcare Share Price Today

(NASDAQ: IXHL)

Incannex Healthcare share price is $0.83 & ₹71.40 as on 22 Mar 2025, 2.30 'hrs' IST

$0.83

-0.01

(-1.7%)

Market is closed - opens 7 PM, 24 Mar 2025

View live Incannex Healthcare share price in Dollar and Rupees. Guide to invest in Incannex Healthcare stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Incannex Healthcare, along with analyst recommendations, forecasts, and comprehensive financials.

Incannex Healthcare share price movements

  • Today's Low: $0.81
    Today's High: $0.88

    Day's Volatility :7.95%

  • 52 Weeks Low: $0.73
    52 Weeks High: $3.60

    52 Weeks Volatility :79.72%

Incannex Healthcare (IXHL) Returns

PeriodIncannex Healthcare LtdIndex (Russel 2000)
3 Months
-50.67%
0.0%
6 Months
-59.58%
0.0%
1 Year
-73.69%
0.0%
3 Years
-92.56%
-14.8%

Incannex Healthcare (IXHL) Key Statistics

in dollars & INR

Previous Close
$0.843
Open
$0.88
Today's High
$0.88
Today's Low
$0.81
Market Capitalization
$22.8M
Today's Volume
$14.7K
52 Week High
$3.6
52 Week Low
$0.73
Revenue TTM
$98.0K
EBITDA
$-21.8M
Earnings Per Share (EPS)
$-1.42
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-240.0%

How to invest in Incannex Healthcare Stock (IXHL) from India?

It is very easy for Indian residents to invest directly in Incannex Healthcare from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Incannex Healthcare stock in both Indian Rupees (INR) and US Dollars (USD). Search for Incannex Healthcare or IXHL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Incannex Healthcare or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Incannex Healthcare shares which would translate to 1.036 fractional shares of Incannex Healthcare as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Incannex Healthcare, in just a few clicks!

Returns in Incannex Healthcare (IXHL) for Indian investors in Rupees

The Incannex Healthcare stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Incannex Healthcare investment value today

Current value as on today

₹29,587

Returns

₹70,413

(-70.41%)

Returns from Incannex Healthcare Stock

₹73,651 (-73.65%)

Dollar Returns

₹3,238 (+3.24%)

Indian investors sentiment towards Incannex Healthcare (IXHL)

-62%

Period: Feb 21, 2025 to Mar 23, 2025. Change in 30 Days versus previous period

Search interest for Incannex Healthcare Stock from India on INDmoney has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Incannex Healthcare

  • AdvisorShares Investments, LLC

    0.93%

  • Morgan Stanley - Brokerage Accounts

    0.32%

  • Jane Street Group LLC

    0.26%

  • Bridgeway Capital Management, LLC

    0.14%

  • Barclays PLC

    0.13%

  • Squarepoint Ops LLC

    0.06%

Analyst Recommendation on Incannex Healthcare

Insights on Incannex Healthcare Stock (Ticker Symbol: IXHL)

  • Price Movement

    In the last 7 days, IXHL stock has moved up by 12.0%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 74.0K → 12.0K (in $), with an average decrease of 83.8% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -5.42M → -5.89M (in $), with an average decrease of 8.8% per quarter
  • IXHL vs ITCI (1 yr)

    In the last 1 year, Intra-cellular Therapies, Inc. has given 90.7% return, outperforming this stock by 160.7%
  • IXHL vs ITCI (3 yr)

    In the last 3 years, Intra-cellular Therapies, Inc. has given 121.7% return, outperforming this stock by 214.7%
  • Price to Sales

    ForIXHL every $1 of sales, investors are willing to pay $138.1, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

Incannex Healthcare Technicals Summary

Sell

Neutral

Buy

Incannex Healthcare is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Incannex Healthcare (IXHL) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Incannex Healthcare Ltd logo
-44.75%
-59.58%
-73.69%
-92.56%
-94.43%
Intra-cellular Therapies, Inc. logo
2.4%
73.66%
93.69%
116.6%
771.28%
Haleon Plc Spon Ads logo
1.28%
-3.29%
21.95%
38.73%
38.73%
Zoetis Inc. logo
-1.38%
-15.79%
-2.85%
-13.94%
50.66%
Viatris Inc. logo
-19.67%
-20.23%
-22.65%
-18.23%
-44.0%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Incannex Healthcare Ltd logo
NA
NA
NA
0.0
-2.4
-0.82
NA
0.05
Intra-cellular Therapies, Inc. logo
NA
NA
0.0
0.13
-0.09
-0.07
NA
10.81
Haleon Plc Spon Ads logo
25.07
25.07
1.85
0.37
0.09
0.05
0.02
1.79
Zoetis Inc. logo
29.75
29.75
2.88
6.07
0.51
0.15
0.01
10.64
Viatris Inc. logo
224.4
NA
0.15
2.2
-0.03
0.02
0.05
15.61
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Incannex Healthcare Ltd logo
NA
$22.8M
-94.43%
NA
0.0%
Intra-cellular Therapies, Inc. logo
Buy
$14.0B
771.28%
NA
-10.97%
Haleon Plc Spon Ads logo
Buy
$46.5B
38.73%
25.07
12.84%
Zoetis Inc. logo
Buy
$73.0B
50.66%
29.75
26.86%
Viatris Inc. logo
Hold
$10.9B
-44.0%
224.4
-4.3%

About Incannex Healthcare

Incannex Healthcare Inc., a clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia. The company develops IHL-42X, an oral fixed dose combination of dronabinol and acetazolamide that has completed Phase 2/3 clinical trial for the treatment of obstructive sleep apnea; and PSX-001, an oral synthetic psilocybin treatment in Phase 2b clinical development for patients with generalized anxiety disorder. It is also developing IHL-675A, an oral fixed dose combination drug containing synthetic cannabidiol and hydroxychloroquine sulphate in Phase 2 clinical trial to treat rheumatoid arthritis, as well as lung inflammation, acute respiratory disease, chronic obstructive pulmonary disease, asthma, bronchitis, inflammatory bowel disease, colitis, and Crohn's disease. Incannex Healthcare Inc. is headquartered in Sydney, Australia.
Organization
Incannex Healthcare
Employees
9
CEO
Mr. John Michailidis B.Sc., EMBA, M.A.I.C.D.
Industry
Miscellaneous

Management People of Incannex Healthcare

NameTitle
Mr. Joel Bradley Latham
President, CEO & Executive Director
Mr. Joseph Swan
CFO, Treasurer & Secretary
Mr. Lekhram Changoer M.Sc.
CTO & Member of Advisory Board
Dr. Mark Bleackley Ph.D.
Chief Scientific Officer, Head of Programs & Member of the Advisory Board
Mr. John Michailidis B.Sc., EMBA, M.A.I.C.D.
Chief Executive Officer of IncannexTM
Natalie May
Head of Clinical Operations
Dr. Luigi M. Barbato M.D.
Chief Medical Officer

Important FAQs about investing in IXHL Stock from India :

What is Incannex Healthcare share price today?

Incannex Healthcare share price today stands at $0.83, Open: $0.88 ; Previous Close: $0.84 ; High: $0.88 ; Low: $0.81 ; 52 Week High: $3.60 ; 52 Week Low: $0.73.

The stock opens at $0.88, after a previous close of $0.84. The stock reached a daily high of $0.88 and a low of $0.81, with a 52-week high of $3.60 and a 52-week low of $0.73.

Can Indians buy Incannex Healthcare shares?

Yes, Indians can invest in the Incannex Healthcare (IXHL) from India.

With INDmoney, you can buy Incannex Healthcare at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Incannex Healthcare at zero transaction cost.

How can I buy Incannex Healthcare shares from India?

It is very easy to buy Incannex Healthcare from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Incannex Healthcare (IXHL) be purchased?

Yes, you can buy fractional shares of Incannex Healthcare with INDmoney app.

What are the documents required to start investing in Incannex Healthcare stocks?

To start investing in Incannex Healthcare, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Incannex Healthcare Stock (IXHL)?

Today’s highest price of Incannex Healthcare (IXHL) is $0.88.

Today’s lowest price of Incannex Healthcare (IXHL) is $0.81.

What is today's market capitalisation of Incannex Healthcare?

Today's market capitalisation of Incannex Healthcare IXHL is 22.8M

What is the 52 Week High and Low Range of Incannex Healthcare Stock (IXHL)?

  • 52 Week High

    $3.60

  • 52 Week Low

    $0.73

What are the historical returns of Incannex Healthcare (IXHL)?

  • 1 Month Returns

    -44.75%

  • 3 Months Returns

    -59.58%

  • 1 Year Returns

    -73.69%

  • 5 Years Returns

    -94.43%

Who is the Chief Executive Officer (CEO) of Incannex Healthcare ?

Mr. John Michailidis B.Sc., EMBA, M.A.I.C.D. is the current Chief Executive Officer (CEO) of Incannex Healthcare.